Theratechnologies Inc.: Mexico Approves the 1mg/vial Presentation of EGRIFTA(R) (tesamorelin for injection)
MONTREAL, CANADA -- (Marketwired) -- 03/08/16 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that COFEPRIS, Mexico's health agency, has approved the 1mg/vial presentation of tesamorelin for the reduction of excess …